Beth Slaunwhite was diagnosed with pulmonary hypertension (PH) after years of being misdiagnosed and struggling with ...

New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black ...

Mechanical thrombectomy (MT), another invasive treatment method has been shown to reduce thrombus burden and pulmonary artery ...

The lungs’ blood arteries differ from those of the rest of the body. This distinction is obvious in pulmonary hypertension, ...

Over 150 experts and patient representatives from across globe came together at Ferrer’s IMPAHCT conference 2024 to address ...

In Merck’s quarterly conference call on Thursday, it took CEO Rob Davis less than a minute to tout newly approved pulmonary ...

Merck on Thursday reported first-quarter results that beat analysts’ expectations amid strong sales of vaccines and cancer ...

The genes ISG15 and IFI27 are hub genes involved in the IFN response pathway, especially in important infection-fighting ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) ...

United Therapeutics‘ UTHR first-quarter 2024 earnings of $6.17 per share beat the Zacks Consensus Estimate of $5.63. Earnings rose 27% year over year on the back of higher product sales.Revenues were ...

Anticipated growth for ‘Saudi Arabia Pulmonary Arterial Hypertension Market’ is significant from 2024 to 2032. The market ...

Report Ocean’s latest analysis delves into the “Vietnam Pulmonary Arterial Hypertension Market” Report from 2024 to 2032, ...